about
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trialRegeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody.The CD23b promoter is a target for NF-AT transcription factors in B-CLL cellsDoes Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study.Effective B cell depletion with rituximab in the treatment of autoimmune diseases.Rituximab in patients with rheumatoid arthritis in routine practice (GERINIS): six-year results from a prospective, multicentre, non-interventional study in 2,484 patientsImpact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational studyNuclear Pore Protein p62 Autoantibodies in Systemic Lupus ErythematosusCD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis.Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).Expression of K2P5.1 potassium channels on CD4+ T lymphocytes correlates with disease activity in rheumatoid arthritis patientsEvaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trialRenal perfusion in scleroderma patients assessed by microbubble-based contrast-enhanced ultrasoundPsoriatic arthritis: clinical spectrum and diagnostic procedures.Sustained Remission After Combination Therapy with Rituximab and Etanercept in Two Patients with Rheumatoid Arthritis After TNF Failure: Case Report.Psoriatic arthritis: therapeutic principles.German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs.Nucleoporin p62 antibodies in a case of mixed connective tissue disease.Pax-5 is a key regulator of the B cell-restricted expression of the CD23a isoform.Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis.Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment.A randomised, double-blind trial to demonstrate bioequivalence of GP2013 and reference rituximab combined with methotrexate in patients with active rheumatoid arthritis.Short-term cytokine stimulation reveals regulatory T-cells with down-regulated Foxp3 expression in human peripheral blood.Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis.Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritisHuman regulatory T cells are selectively activated by low-dose application of the CD28 superagonist TGN1412/TAB08.Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.In vivo effects of the anti-interleukin-6 receptor inhibitor tocilizumab on the B cell compartment.Steady-state generation of mucosal IgA+ plasmablasts is not abrogated by B-cell depletion therapy with rituximab.Impact of IL-6 receptor inhibition on human memory B cells in vivo: impaired somatic hypermutation in preswitch memory B cells and modulation of mutational targeting in memory B cells.Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).A 58-year-old man with respiratory insufficiency after a 50-year history of hypersensitivity pneumonitis and pulmonary Aspergillus infections.Gammadelta T cells for immune therapy of patients with lymphoid malignancies.Dr. Roll, et al reply.Rituximab therapy leads to reduced imprints of receptor revision in immunoglobulin κ and λ light chains.Sun-induced life-threatening lupus nephritis.Lymphoplasmacytic lymphoma in a patient with leaking silicone implant.Semiquantitative and qualitative assessment of B-lymphocyte V H repertoire by a fluorescent multiplex PCR.
P50
Q19862843-616CF9DB-8DF6-477E-AFA2-5405E2706845Q24817041-A29C2B92-473A-46E3-B39B-54AA3A302E31Q28207529-E9BD4C66-40BF-4882-A804-B2A5700DAFE9Q31032210-FB358B05-A103-426B-8CFB-2462205466ACQ33346694-CA629E50-9432-4D46-A3DD-36A12A4CF9D1Q33765608-DEDB9E0D-2C31-465C-B22E-3BB124989689Q33984823-0C1CAB47-9E92-4875-9604-A3ED4D4C2F8CQ34002278-C308FBAE-C18D-465C-8141-049FDB680357Q35555943-22DB800A-69CF-4526-995C-87FCAD778E92Q35557832-0B5428CE-225E-4FE9-82D5-6987413C385BQ35620325-9F66D380-2FD8-4235-8F37-F95BAC457CB6Q35654020-CF815F65-159D-4894-A3DA-2D3675FB4E34Q36008482-C37A7B22-8716-4A6C-B743-14993AE7C7C4Q37005251-572C2D5C-8C79-4679-9ECC-88E1A0D213DFQ37198597-EBFAB61B-15E8-447B-856B-ECEDAF213BB5Q37255466-65047FF8-9510-4479-82FB-EBC91DB42ADCQ38128726-1C063F61-B688-431B-96D0-01294EC1B47CQ38788961-9725FF2A-3300-4C7C-A805-9709089EF834Q39669606-5A6F82A1-0F78-4258-9D5B-E27F205DA8CEQ39736322-09CA4DC8-0944-4A4F-B243-04D53A716F0EQ40649997-23569072-6BF8-4D61-A0C8-8FFE9AA64A4EQ40775250-2931138B-D23D-4750-A9E7-742BBA266E45Q41026649-32AB84B9-A4F0-4EF6-AF7E-E5727C0E513DQ41449525-6E55D578-A645-4941-8469-3D1C6E6A8A9EQ41918204-7B60A69A-4832-45E2-9ACF-6D9B6313511CQ42053368-AC6085F4-6F3A-40BC-8B58-0C9058271A94Q42096435-1A2C004D-358E-47B3-B2E6-19E22F29E783Q42246343-5B63A8D2-9D55-4C39-98AD-0B413688D018Q42657379-C97B9664-EC75-432D-A02B-3A205BA48E0AQ42689640-4AC75A89-7107-4C15-BB48-D5676171E343Q42911721-74287D77-3479-451C-87B3-91FE2AAB54B2Q43487327-567E62F1-A367-47AF-910C-040373CDD84EQ43855238-193800C2-99DE-4468-839A-BA8AE9688C3CQ44223565-5B0DEA4A-01BB-4847-A3A2-ADA87E2818C6Q44353687-F66AB234-DB35-4C40-AA14-34BF5847EF8BQ44907779-C27ED823-4244-4BE9-9FD8-575A005D0CC0Q45830944-C6E4CFB1-FB84-40AF-AD01-98F9E2BBEFF6Q46982885-F6F695AE-3BDD-4E1A-A1E4-C49B603DE8C4Q47790225-CF95F9C3-CEAE-4558-9AEE-2B952C911859Q47924884-B3C6E9D6-5B3E-4BD7-988F-6F20FC748B91
P50
description
auteur
@nl
name
Hans-Peter Tony
@ast
Hans-Peter Tony
@en
Hans-Peter Tony
@es
Hans-Peter Tony
@nl
type
label
Hans-Peter Tony
@ast
Hans-Peter Tony
@en
Hans-Peter Tony
@es
Hans-Peter Tony
@nl
altLabel
HP Tony
@en
prefLabel
Hans-Peter Tony
@ast
Hans-Peter Tony
@en
Hans-Peter Tony
@es
Hans-Peter Tony
@nl